ATE261724T1 - Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen - Google Patents

Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen

Info

Publication number
ATE261724T1
ATE261724T1 AT99951502T AT99951502T ATE261724T1 AT E261724 T1 ATE261724 T1 AT E261724T1 AT 99951502 T AT99951502 T AT 99951502T AT 99951502 T AT99951502 T AT 99951502T AT E261724 T1 ATE261724 T1 AT E261724T1
Authority
AT
Austria
Prior art keywords
traaumatic
post
treatment
stress diseases
anticonvulsive
Prior art date
Application number
AT99951502T
Other languages
English (en)
Inventor
Kammen Daniel P Van
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of ATE261724T1 publication Critical patent/ATE261724T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
AT99951502T 1998-11-17 1999-10-12 Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen ATE261724T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10880598P 1998-11-17 1998-11-17
PCT/US1999/021612 WO2000028945A2 (en) 1998-11-17 1999-10-12 Anticonvulsant derivatives useful in treating post traumatic stress disorder

Publications (1)

Publication Number Publication Date
ATE261724T1 true ATE261724T1 (de) 2004-04-15

Family

ID=22324143

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99951502T ATE261724T1 (de) 1998-11-17 1999-10-12 Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen

Country Status (15)

Country Link
US (1) US6472370B1 (de)
EP (1) EP1143917B1 (de)
CN (1) CN1326346A (de)
AT (1) ATE261724T1 (de)
AU (1) AU764510B2 (de)
BR (1) BR9915434A (de)
CA (1) CA2351658C (de)
DE (1) DE69915690T2 (de)
DK (1) DK1143917T3 (de)
ES (1) ES2217819T3 (de)
HU (1) HUP0105037A3 (de)
NO (1) NO20012423L (de)
NZ (1) NZ511881A (de)
PT (1) PT1143917E (de)
WO (1) WO2000028945A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003500444A (ja) * 1999-05-28 2003-01-07 ジェフリー バーラント, 心的外傷後ストレス障害の処置のための化合物および方法
CA2430010A1 (en) 2000-11-30 2002-06-06 University Of Florida Treatments for neurogenetic disorders, impulse control disorders, and wound healing
EP1539157B1 (de) 2002-09-18 2013-08-21 Trustees Of The University Of Pennsylvania Rapamycin zur Verwendung in der Hemmung oder Vorbeugung der choroidalen Neovaskularisation
BRPI0608152A2 (pt) 2005-02-09 2009-11-10 Macusight Inc formulações para tratamento ocular
WO2007092620A2 (en) 2006-02-09 2007-08-16 Macusight, Inc. Stable formulations, and methods of their preparation and use
PL2001466T3 (pl) 2006-03-23 2016-06-30 Santen Pharmaceutical Co Ltd Rapamycyna w małej dawce do leczenia chorób związanych z przepuszczalnością naczyń
US20090076128A1 (en) * 2007-09-15 2009-03-19 Protia Llc Deuterium-enriched topiramate
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US5753693A (en) 1996-06-28 1998-05-19 Ortho Pharmaceutical Corporation Anticonvulsant derivatives useful in treating manic-depressive bipolar disorder

Also Published As

Publication number Publication date
DE69915690D1 (de) 2004-04-22
HUP0105037A2 (hu) 2002-04-29
US6472370B1 (en) 2002-10-29
DE69915690T2 (de) 2005-02-24
NO20012423D0 (no) 2001-05-16
CA2351658C (en) 2006-07-11
AU6393399A (en) 2000-06-05
WO2000028945A3 (en) 2001-09-20
WO2000028945A2 (en) 2000-05-25
BR9915434A (pt) 2001-12-04
PT1143917E (pt) 2004-06-30
ES2217819T3 (es) 2004-11-01
CA2351658A1 (en) 2000-05-25
NZ511881A (en) 2004-12-24
EP1143917A3 (de) 2002-01-02
EP1143917A2 (de) 2001-10-17
NO20012423L (no) 2001-05-16
CN1326346A (zh) 2001-12-12
DK1143917T3 (da) 2004-06-01
AU764510B2 (en) 2003-08-21
EP1143917B1 (de) 2004-03-17
HUP0105037A3 (en) 2003-01-28

Similar Documents

Publication Publication Date Title
ATE350030T1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
DK1143967T3 (da) Anticonvulsive derivater egnede til behandling af Hortons hovedpine
ATE235481T1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
ATE224189T1 (de) Antikonvulsive sulfamatderivate zur behandlung von fettleibigkeit
DE60023043T2 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
ATE279181T1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
DE59902314D1 (de) Oligomerisiertes Organopolysiloxan-Cokondensat, dessen Herstellung und dessen Verwendung zur Behandlung von Oberflächen
ATE455106T1 (de) Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen
NO20000752L (no) Metode for forhindring eller behandling av østrogen-avhengige sykdommer og forstyrrelser
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69936890D1 (de) Vorrichtung zur Behandlung von Ischämie
ATE315390T1 (de) Zyklische polyamine zur behandlung der thrombozytopenie
DE69936285D1 (de) INDOLOi2,1-BöQUINAZOLIN-6,12-DIONE ANTIMALARIA DERIVATE UND METHODEN ZUR BEHANDLUNG VON MALARIA
ATE275400T1 (de) Verwendung von melatonin zur behandlung der androgenetischen und diffusen alopezie vom weiblichen typ
DE69711078D1 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
ATE261724T1 (de) Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen
ATE332688T1 (de) Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung
TR200103125T2 (tr) Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri.
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
TR200200278T2 (tr) Kalsilitik bileşimler
ATE262362T1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
BR0008791A (pt) Derivados anticonvulsivos, úteis no tratamento de tremor essencial
DE69806062T2 (de) Kombinationstherapie zur behandlung von aids
ATE204167T1 (de) Antikonvulsive derivate zur behandlung von psoriasis
DE69924385D1 (de) Verwendung von angiotensin zur behandlung von krebsmetastasierung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1143917

Country of ref document: EP

REN Ceased due to non-payment of the annual fee